• GenVec Inc., of Gaithersburg, Md., presented data related to its malaria vaccine program at the American Society of Tropical Medicine and Hygiene meeting in Atlanta. The data showed that the new antigens are as protective as circumsporozoite protein (CSP) in a mouse model of malaria.